Veeva Systems Acquires Copli, Launches Falcon MLR Platform
Veeva Systems expands its life sciences software suite with the Copli acquisition and a new AI-driven MLR review tool.
Veeva Systems has acquired Copli and simultaneously launched Veeva Falcon MLR, a new artificial intelligence-powered medical, legal, and regulatory review platform aimed squarely at life sciences companies, the enterprise software giant announced. The dual move signals an aggressive push by Veeva to deepen its grip on the compliance and content review workflows that pharmaceutical and biotech firms depend on daily.
The Copli acquisition brings additional technology and talent into Veeva's growing portfolio, reinforcing the company's strategy of building end-to-end solutions for drug makers navigating complex regulatory environments. By folding Copli's capabilities into its ecosystem, Veeva aims to accelerate development of tools that reduce the time and friction involved in getting promotional and medical content through review cycles.
Read more Apple Quietly Passes AI Infrastructure Costs to Consumers →
Veeva Falcon MLR is positioned as a purpose-built solution that applies machine learning to streamline the MLR process — a notoriously bottlenecked stage in life sciences marketing and medical affairs operations. Faster, more accurate reviews could translate directly into shorter time-to-market for compliant content, a significant competitive advantage for biopharma companies operating under tight regulatory scrutiny.
The moves come as Veeva continues its post-Salesforce independence strategy, doubling down on vertical cloud software tailored exclusively for life sciences. Analysts have watched the company carefully since its platform pivot, and acquisitions like Copli suggest management is willing to buy capabilities rather than build everything organically when speed to market demands it.
Continue reading at Yahoo Finance
